R01 CA062275/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	1
2001	1
2002	2
2003	1
2004	1
2007	1
2008	2
2010	1
2011	2
2012	2
2013	2
2014	3
2015	6
2016	2
2025	0

1

Wei LN, Dmintrovsky E. Wei LN, et al. FASEB J. 2015 Apr;29(4):1131-5. doi: 10.1096/fj.15-0402ufm. FASEB J. 2015. PMID: 25834129 Free PMC article. No abstract available.

2

Cyclin degradation for cancer therapy and chemoprevention.

Freemantle SJ, Liu X, Feng Q, Galimberti F, Blumen S, Sekula D, Kitareewan S, Dragnev KH, Dmitrovsky E. Freemantle SJ, et al. J Cell Biochem. 2007 Nov 1;102(4):869-77. doi: 10.1002/jcb.21519. J Cell Biochem. 2007. PMID: 17868090 Review.

3

Cyclin proteolysis as a retinoid cancer prevention mechanism.

Dragnev KH, Freemantle SJ, Spinella MJ, Dmitrovsky E. Dragnev KH, et al. Ann N Y Acad Sci. 2001 Dec;952:13-22. doi: 10.1111/j.1749-6632.2001.tb02724.x. Ann N Y Acad Sci. 2001. PMID: 11795432 Review.

4

Mice lacking G0S2 are lean and cold-tolerant.

Ma T, Lopez-Aguiar AG, Li A, Lu Y, Sekula D, Nattie EE, Freemantle S, Dmitrovsky E. Ma T, et al. Cancer Biol Ther. 2014 May;15(5):643-50. doi: 10.4161/cbt.28251. Epub 2014 Feb 20. Cancer Biol Ther. 2014. PMID: 24556704 Free PMC article.

5

Evidence for the ubiquitin protease UBP43 as an antineoplastic target.

Guo Y, Chinyengetere F, Dolinko AV, Lopez-Aguiar A, Lu Y, Galimberti F, Ma T, Feng Q, Sekula D, Freemantle SJ, Andrew AS, Memoli V, Dmitrovsky E. Guo Y, et al. Mol Cancer Ther. 2012 Sep;11(9):1968-77. doi: 10.1158/1535-7163.MCT-12-0248. Epub 2012 Jul 2. Mol Cancer Ther. 2012. PMID: 22752428 Free PMC article.

6

G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program.

Yim CY, Sekula DJ, Hever-Jardine MP, Liu X, Warzecha JM, Tam J, Freemantle SJ, Dmitrovsky E, Spinella MJ. Yim CY, et al. Cancer Res. 2016 Mar 1;76(5):1204-13. doi: 10.1158/0008-5472.CAN-15-2265. Epub 2016 Feb 2. Cancer Res. 2016. PMID: 26837760 Free PMC article.

7

MCL1 enhances the survival of CD8+ memory T Cells after viral infection.

Gui J, Hu Z, Tsai CY, Ma T, Song Y, Morales A, Huang LH, Dmitrovsky E, Craig RW, Usherwood EJ. Gui J, et al. J Virol. 2015 Feb;89(4):2405-14. doi: 10.1128/JVI.02480-14. Epub 2014 Dec 10. J Virol. 2015. PMID: 25505074 Free PMC article.

8

Retinoids and rexinoids in cancer prevention: from laboratory to clinic.

Uray IP, Dmitrovsky E, Brown PH. Uray IP, et al. Semin Oncol. 2016 Feb;43(1):49-64. doi: 10.1053/j.seminoncol.2015.09.002. Epub 2015 Sep 25. Semin Oncol. 2016. PMID: 26970124 Free PMC article. Review.

9

A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity.

Pino-Lagos K, Guo Y, Brown C, Alexander MP, Elgueta R, Bennett KA, De Vries V, Nowak E, Blomhoff R, Sockanathan S, Chandraratna RA, Dmitrovsky E, Noelle RJ. Pino-Lagos K, et al. J Exp Med. 2011 Aug 29;208(9):1767-75. doi: 10.1084/jem.20102358. Epub 2011 Aug 22. J Exp Med. 2011. PMID: 21859847 Free PMC article.

10

Repression of exogenous gene expression by the retinoic acid target gene G0S2.

Ma T, Dong JP, Sekula DJ, Fei DL, Lamph WW, Henderson M, Lu Y, Blumen S, Freemantle SJ, Dmitrovsky E. Ma T, et al. Int J Oncol. 2013 May;42(5):1743-53. doi: 10.3892/ijo.2013.1876. Epub 2013 Mar 28. Int J Oncol. 2013. PMID: 23546556 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year